Australian scientists have demonstrated a new way to restore insulin production in pancreatic cells, using a drug that's already approved for use in humans. The study could mark a major breakthrough towards new treatments for diabetes. Blood glucose levels are managed by the hormone insulin, which is produced in beta cells in the pancreas.

It is estimated by The National Kidney Foundation that over 100,000 patients are on the waiting list for kidney donors. A further 3,000 names are added to the list every year. An average patient has to wait for 3.6 years for a viable transplant.